: Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
: These are the 5 most damning things FTX’s new CEO has to say about Sam Bankman-Fried
John J. Ray III is set to lay out an alarming picture to Congress of how badly mismanaged the crypto exchange really was.
: U.S. oil futures settle 3% higher on supply worries
U.S. oil futures finished higher on Monday, finding support as supply concerns resurfaced. “Recession or not, people still need to fill their gas tanks,” so...
S&P 500, Nasdaq trade near session highs in final hour of trading
U.S. stocks remained higher in the final hour of trading on Monday, with the S&P 500 and Nasdaq Composite indexes trading near New York session...
Coronavirus Update: COVID cases continue upward march as new, more infectious variants emerge and as flu, RSV and other respiratory illnesses spread
U.S. known cases of COVID continued to rise steadily on Monday, along with hospitalizations, fatalities and test-positivity rates.
Commodities Corner: Gasoline prices are down 5 week in a row, but an end to the declines may be on tap: GasBuddy
U.S. retail gasoline prices have declined for five weeks in a row, with average prices on track to fall below $3 by Christmas, says GasBuddy.
Economic Report: Inflation is slowing, CPI to show, but it’s still a big problem
The high rate of U.S. inflation probably slowed again in November, but not enough to ease worries at the Federal Reserve or prevent the central...
Economic Report: U.S. budget deficit widens to $248.5 billion in November
The U.S. budget deficit widened to $248.5 billion in November, up from $191.3 billion in the same month last year, the Treasury Department said Monday.
The Tell: Here’s ‘another problem’ for the U.S. stock market in 2023, says RBC
A struggling U.S. stock market will next year have to contend with relatively attractive European equities after a recent shift toward value stocks, according to...